Omeros Corporation Stock Prediction
AI-powered sentiment analysis and prediction trends for OMER, updated each market day.
OMER AI Sentiment
AI predicts Omeros Corporation stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Omeros Corporation
Omeros Corp is an inventive, commercial-stage biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for large-market and orphan indications, with particular emphasis on complement-mediated diseases, cancers, and addictive or compulsive disorders. The company's clinical-stage development programs include: narsoplimab, its antibody targeting mannan-binding lectin-associated serine protease 2 (MASP-2), the effector enzyme of the lectin pathway of complement; OMS1029, its long-acting antibody targeting MASP-2; and OMS527, its phosphodiesterase 7 (PDE7) inhibitor program.
Sector
Exchange
Market Cap
$857,474,396
Cap Tier
Employees
175
Headquarters
SEATTLE, WA
Listed Since
Oct. 8, 2009
Website
OMER Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
OMER Volatility
Omeros Corporation has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
